The access to oncology drugs in France, Germany, Italy, Spain, and the United Kingdom: A comparison based on data from 1998 to 2007

被引:0
|
作者
Wilking, N. E.
Jonsson, B.
机构
[1] Karolinska Inst, Stockholm, Sweden
[2] Stockholm Sch Econ, S-11383 Stockholm, Sweden
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
6525
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Use of oncology drugs in Japan compared to France, Germany, Italy, Spain, Sweden, the United Kingdom, and the United States: A comparison based on data from 1999 to 2009
    Wilking, N. E.
    Hogberg, D.
    Jonsson, B.
    Koinuma, N.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [2] ACCESS TO ORPHAN ONCOLOGY DRUGS IN FRANCE VERSUS THE UNITED KINGDOM
    Esmail, S.
    Grosvenor, A. S.
    [J]. VALUE IN HEALTH, 2012, 15 (04) : A18 - A18
  • [3] Burden of vasomotor symptoms in France, Germany, Italy, Spain, and the United Kingdom
    DiBonaventura, Marco daCosta
    Chandran, Arthi
    Hsu, Ming-Ann
    Bushmakin, Andrew
    [J]. INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2013, 5 : 261 - 269
  • [4] The burden of cancer in Japan, the United States, France, Germany, Italy, Spain, Sweden, and the United Kingdom
    Koinuma, N.
    Wilking, N. E.
    Jonsson, B.
    Hogberg, D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [5] EARLY ACCESS PROGRAMS: A COMPARISON BETWEEN FRANCE, GERMANY AND THE UNITED KINGDOM
    Ben Younes, K.
    Colonier, Foix A.
    Amzal, B.
    Angehrn, Z.
    Karcher, H.
    [J]. VALUE IN HEALTH, 2018, 21 : S157 - S157
  • [6] Cost of diabetic foot in France, Spain, Italy, Germany and United Kingdom: A systematic review
    Tchero, Huidi
    Kangambega, Pauline
    Lin, Lucien
    Mukisi-Mukaza, Martin
    Brunet-Houdard, Solenne
    Briatte, Christine
    Retali, Gerald Reparate
    Rusch, Emmanuel
    [J]. ANNALES D ENDOCRINOLOGIE, 2018, 79 (02) : 67 - 74
  • [7] EXPLAINING THE DISPARITIES OF MARKET ACCESS FOR GLIFLOZINS IN FRANCE, SPAIN, GERMANY AND THE UNITED-KINGDOM
    Bodaghi, C.
    Benque, E.
    Troubat, A.
    [J]. VALUE IN HEALTH, 2018, 21 : S134 - S134
  • [8] Global Spending on Orphan Drugs in France, Germany, the UK, Italy and Spain during 2007
    Orofino, Javier
    Soto, Javier
    Casado, Miguel A.
    Oyagueez, Itziar
    [J]. APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2010, 8 (05) : 301 - 315
  • [9] The impact of COVID-19 on fertility plans in Italy, Germany, France, Spain, and the United Kingdom
    Luppi, Francesca
    Arpino, Bruno
    Rosina, Alessandro
    [J]. DEMOGRAPHIC RESEARCH, 2020, 43 : 1399 - 1412
  • [10] ADHERENCE TO TREATMENT AND PERSISTENCY IN PATIENTS TREATED WITH VKA IN FRANCE, ITALY, GERMANY, SPAIN AND THE UNITED KINGDOM
    Carrasco, J.
    Cotte, F. E.
    Lomon, Duprat, I
    Letierce, A.
    Huguet, M.
    Marchant, N.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A516 - A516